Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Simply put, in the eyes of federal law, cannabis is illegal. According to Federal law, cannabis use is illegal. 5520), and the Veterans Equal Access Act (H.R.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

OCTOBER 4, 2021

In Attorney , Federal Law , Kathryn Tucker , Oregon , Psychedelics. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. September 30, 2021. Kathryn Tucker.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

JUNE 16, 2022

Federal law enforcement agents and their partners seized over 5.5 According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Program Statistical Report, agents and their partners confiscated approximately 5.53 million cultivated cannabis plants last year – a 20 percent increase over 2020’s totals.

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

CannaMD

SEPTEMBER 15, 2020

What law legalized medical marijuana in Florida? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. How does Florida law define medical marijuana? ” Translation?

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. The report goes on to describe how its recommendations would help resolve some of these issues.

Policy 40

Policy Research and Development Marijuana DEA 40

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. Below is a list of state law updates to look forward to this year. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP.

Dispensary 52

Dispensary Law Concentrates DEA 52

Veriheal

NOVEMBER 6, 2023

Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Whether you’re planning a long road trip or flying to see family over the holidays — the following will ensure you stay on the right side of the law. >> Learn more: Where is Cannabis Legal?

Legalization 117

Legalization Recreational THC CBD 117

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 1669, 1670 (2021) (arguing that patents on psychedelics may limit research, innovation, and public access). Glenn Cohen, Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization , 27 NATURE MED.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

NOVEMBER 4, 2021

Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”. We’re beyond that.”. The FDA Director role continues to be unfilled.

DEA 52

DEA Marijuana Decriminalization Data 52

Canna Law Blog

JULY 14, 2023

You can access the letters here. But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. FTC Policy Statement on Deception, 103 F.T.C. For now, stay tuned to the Canna Law Blog for more updates on FDA and FTC cannabinoid policies and delta-8 products.

Packaging 74

Packaging Food Edibles THC 74

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA).

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 23, 2021

Today, adult use of cannabis, which is classified as a Schedule 1 controlled substance under the Controlled Substances Act (CSA), is legal in 18 states, and the medical use of cannabis is legal in 37 states, though cannabis use remains illegal under federal law. Decriminalization of Cannabis, Recognition of State law Controlling Cannabis.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Veriheal

AUGUST 24, 2022

Now, a psychedelic-focused bill aimed at reforming laws surrounding psychedelics further in the state has successfully qualified for the November ballot. This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. The National Organization for the Reform of Marijuana Laws (NORML). NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. The National Organization for the Reform of Marijuana Laws (NORML). NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy.

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. The panel would center on the evolution of cannabis policy in the U.S.,

Research and Development 52

Research and Development Events Topical Policy 52

Veriheal

DECEMBER 27, 2022

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. Study findings indicated that those who had previously taken LSD and psilocybin reported a greater sense of “nature relatedness.”

Research and Development 95

Research and Development Therapy Consumption DEA 95

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. According to the DEA order, because the drug was recently approved by the FDA, it is now considered to have an accepted medical use.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Canna Law Blog

JANUARY 11, 2022

This is all very bad and we collectively need to figure out how to get people to comply with state law rather than penalizing everything. The issue of enforcement or compliance is probably the biggest one most states face at the policy level. And we have a massive illicit market. This left enforcement to state regulators.

Compliance 78

Compliance Compliance State Laws DEA 78

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 352

Cultivation DEA Clinical Trials Marijuana 352

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

Cannabis Law Report

JULY 1, 2021

From their blog… Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative. On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation.

Law 105

Law Research and Development Therapy DEA 105

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC. Research quality” cannabis sparked earlier controversy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Canna Law Blog

NOVEMBER 6, 2021

But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

NOVEMBER 2, 2021

The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities. Illegal Limits of Delta-9 THC. Photo: CBD Oracle. smoke shops), and also required no proof of age.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

MAY 28, 2022

Despite progress over the past decade, the cannabis industry still struggles to access a fundamental piece of the U.S. The cannabis industry might look like just another business for local police, where legal, but the DEA and other federal agencies have a different outlook. economy: the financial system. The State of Banking.

Banking 52

Banking State Laws Law DEA 52

Cannabis Law Report

SEPTEMBER 1, 2021

The manufacture, distribution, and possession of cannabis is illegal under federal law, which categorizes it as a Schedule 1 controlled substance. This prohibition stands in contrast to the 18 states that have “legalized” recreational cannabis use and the 37 states that have enacted laws regulating cannabis use for medical reasons.

Policy 100

Policy Cannabis Treatment Law 100

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. The AAFP also recognizes that several states have passed laws approving limited recreational use and/or possession of marijuana. Marijuana Possession for Personal Use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. Marketing to Minors Unlike state-regulated cannabis, this new wave of acutely intoxicating substances is easily accessible to minors. percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Veriheal

DECEMBER 21, 2022

President Joe Biden has officially signed a marijuana research bill into law. The law gives the U.S. The law gives the U.S. The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. Descheduling Cannabis.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Canna Law Blog

MARCH 4, 2020

There are questions about the logistics of opening and running one of these types of businesses, given the complex interplay of laws and regulations promulgated by bodies from the U.S. Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Cannabis Law Report

MAY 24, 2022

Issue: Does the Controlled Substance Act, which is a federal law that prohibits the manufacturing and distribution of marijuana, exclude medical necessity as a defense? Under federal law, the Controlled Substances Act implies that marijuana has no acceptable medical use, implicitly prohibiting the use of medical necessity as a defense.

DEA 52

DEA History Medicine Marijuana 52

Cannabis Law Report

JUNE 9, 2021

With constantly shifting guidelines and laws that differ both federally and state-to-state, the prospect of moving with marijuana can be quite the head trip. This is the element of the plant that the law is most interested in. Reports Hire A Helper. The list of cannabis-friendly states is getting longer by the day.

Marijuana 66

Marijuana Edibles DEA THC 66

Cannabis Law Report

JUNE 1, 2021

A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link]. This press release contains “forward-looking statements” within the meaning of applicable securities laws, which involve certain known and unknown risks and uncertainties. state and federal law to U.S. Webcast Information.

Data 95

Data Vaping Supply Chain Business 95